Acadia Pharmaceuticals (ACAD) Cash from Investing Activities Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 116.52% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 38.24% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -22.09% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 30.54% |
| 10 | Acadia Pharmaceuticals | 3.69 Bn | 2.84 Bn | 243.27 Mn | -29.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.91% |
| Dec 31, 2025 | -46.56% |
| Sep 30, 2025 | -92.55% |
| Jun 30, 2025 | 8.11% |
| Mar 31, 2025 | -43.33% |
| Dec 31, 2024 | 19.52% |
| Sep 30, 2024 | 19.20% |
| Jun 30, 2024 | -48.36% |
| Mar 31, 2024 | -34.90% |
| Dec 31, 2023 | 85.63% |
| Sep 30, 2023 | -39.36% |
| Jun 30, 2023 | -52.28% |
| Mar 31, 2023 | 86.65% |
| Dec 31, 2022 | 56.06% |
| Sep 30, 2022 | 15.88% |
| Jun 30, 2022 | -93.55% |
| Mar 31, 2022 | 79.37% |
| Dec 31, 2021 | 33.49% |
| Sep 30, 2021 | -90.55% |
| Jun 30, 2021 | -63.43% |
| Mar 31, 2021 | -29.90% |
| Dec 31, 2020 | -86.28% |
| Sep 30, 2020 | 99.28% |
| Jun 30, 2020 | 49.07% |
| Mar 31, 2020 | -17.61% |
| Dec 31, 2019 | -71.28% |
| Sep 30, 2019 | 27.32% |
| Jun 30, 2019 | 50.73% |
| Mar 31, 2019 | 28.76% |
| Dec 31, 2018 | -74.69% |
| Sep 30, 2018 | 56.40% |
| Jun 30, 2018 | -27.84% |
| Mar 31, 2018 | 32.56% |
| Dec 31, 2017 | -34.76% |
| Sep 30, 2017 | -20.77% |
| Jun 30, 2017 | 36.93% |
| Mar 31, 2017 | 36.34% |
| Dec 31, 2016 | 93.51% |
| Sep 30, 2016 | -239.95% |
| Jun 30, 2016 | 57.71% |
| Mar 31, 2016 | -72.12% |
| Dec 31, 2015 | 53.52% |
| Sep 30, 2015 | 71.31% |
| Jun 30, 2015 | 73.80% |
| Mar 31, 2015 | 114.89% |
| Dec 31, 2014 | 119.74% |
| Sep 30, 2014 | 105.52% |
| Jun 30, 2014 | -132.16% |
| Mar 31, 2014 | -124.71% |
| Dec 31, 2013 | 47.81% |
| Sep 30, 2013 | -49.48% |